3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Recruiting
11
Not yet recruiting
2
Completed
2
Active not recruiting
2
Terminated
1
Suspended
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
217
Neoplasms
196
Carcinoma, Non-Small-Cell Lung
94
Colorectal Neoplasms
92
Prostatic Neoplasms
79
Lung Neoplasms
74
Multiple Myeloma
49
Head and Neck Neoplasms
48
Neoplasm Metastasis
46
Melanoma
46
Pancreatic Neoplasms
44
Leukemia, Myeloid, Acute
41
Carcinoma, Hepatocellular
41
Recurrence
35
Brain Neoplasms
35
Squamous Cell Carcinoma of Head and Neck
34
Ovarian Neoplasms
32
Glioblastoma
30
Uterine Cervical Neoplasms
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Sarcoma
27
Glioma
27
Lymphoma, Non-Hodgkin
26
Lymphoma
26
Stomach Neoplasms
25
Carcinoma, Renal Cell
25
Lymphoma, Follicular
24
Colonic Neoplasms
24
Motor Activity
22
Esophageal Neoplasms
22
Interventions
palbociclib
1
encorafenib
1
Oviposition
1
Drainage
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Digestive System Neoplasms
×
90 days
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled
NCT05039177
2026-03-25
HERKULES-3
Erasca, Inc.
Phase 1/2
Completed
101 enrolled